Also found in: Wikipedia.
CODITCode-Division Testbed
CODITCompartmentalization of Decay in Trees
CODITCompact Diagnostic Test (various locations)
References in periodicals archive ?
Aimmune will retain all current and future pipeline assets developed with the CODIT approach, including AR101, the company's investigational oral biologic desensitisation therapy for peanut allergy, which is currently in Phase 3 clinical development.
Research has shown that 'tree paints,' while popular in the past, actually inhibit the CODIT process and act to harbor insects and decay.
2) What CODIT wall is responsible for preventing decay from spreading into new wood produced after injury?
According to the contract, Aimmune will continue to own all existing and future pipeline assets developed with the CODIT approach.
Aimmune's first investigational biologic product using CODIT, AR101 for the treatment of peanut allergy, has received the FDA's Breakthrough Therapy Designation for the desensitisation of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials.